Header Logo

Connection

Charles Feldman to Community-Acquired Infections

Back to Details
This is a "connection" page, showing publications Charles Feldman has written about Community-Acquired Infections.
Charles Feldman
Connection Strength
14,165
Community-Acquired Infections
  1. Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia. Clin Chest Med. 2025 Mar; 46(1):93-104.
    View in: PubMed
    Score: 0,872
  2. Severe community-acquired pneumonia at a tertiary academic hospital in Johannesburg, South Africa. Respir Med. 2024 Nov-Dec; 234:107823.
    View in: PubMed
    Score: 0,865
  3. The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
    View in: PubMed
    Score: 0,793
  4. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Front Immunol. 2020; 11:577303.
    View in: PubMed
    Score: 0,653
  5. Community-Acquired Pneumonia: A Global Perspective. Semin Respir Crit Care Med. 2020 Aug; 41(4):453-454.
    View in: PubMed
    Score: 0,644
  6. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2020 Aug; 41(4):455-469.
    View in: PubMed
    Score: 0,642
  7. Pneumonia as a systemic illness. Curr Opin Pulm Med. 2018 05; 24(3):237-243.
    View in: PubMed
    Score: 0,554
  8. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci. 2018 Apr 11; 19(4).
    View in: PubMed
    Score: 0,552
  9. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017 12; 75(6):473-485.
    View in: PubMed
    Score: 0,531
  10. Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia. Respirology. 2017 07; 22(5):845-846.
    View in: PubMed
    Score: 0,512
  11. Community-Acquired Pneumonia: A Global Perspective. Semin Respir Crit Care Med. 2016 12; 37(6):797-798.
    View in: PubMed
    Score: 0,503
  12. Community-acquired pneumonia: still a major burden of disease. Curr Opin Crit Care. 2016 10; 22(5):477-84.
    View in: PubMed
    Score: 0,496
  13. Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa. J Infect Dev Ctries. 2016 Apr 28; 10(4):347-53.
    View in: PubMed
    Score: 0,482
  14. Response. Chest. 2016 Feb; 149(2):603-604.
    View in: PubMed
    Score: 0,474
  15. Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies. Chest. 2015 Aug; 148(2):523-532.
    View in: PubMed
    Score: 0,458
  16. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013; 2013:490346.
    View in: PubMed
    Score: 0,410
  17. Pneumococcal disease in the Arabian Gulf: recognizing the challenge and moving toward a solution. J Infect Public Health. 2013 Dec; 6(6):401-9.
    View in: PubMed
    Score: 0,399
  18. Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs. 2011 Jan 22; 71(2):131-53.
    View in: PubMed
    Score: 0,335
  19. Controversies in the treatment of pneumococcal community-acquired pneumonia. Future Microbiol. 2006 Oct; 1(3):271-81.
    View in: PubMed
    Score: 0,248
  20. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Respir Med. 2004 Aug; 98(8):708-20.
    View in: PubMed
    Score: 0,214
  21. CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2004 Jun; 10(6):587-9.
    View in: PubMed
    Score: 0,211
  22. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004 May; 143(5):269-83.
    View in: PubMed
    Score: 0,210
  23. Dual infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in HIV-seropositive patients with community acquired pneumonia. Int J Tuberc Lung Dis. 2003 Dec; 7(12):1207-8.
    View in: PubMed
    Score: 0,204
  24. Pneumonia in the elderly. Med Clin North Am. 2001 Nov; 85(6):1441-59.
    View in: PubMed
    Score: 0,177
  25. Never Let a Good Crisis Go to Waste. Chest. 2021 03; 159(3):917-919.
    View in: PubMed
    Score: 0,169
  26. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa. Int J Antimicrob Agents. 2020 Dec; 56(6):106189.
    View in: PubMed
    Score: 0,164
  27. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel. Chest. 2020 11; 158(5):1912-1918.
    View in: PubMed
    Score: 0,163
  28. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest. 2020 11; 158(5):1896-1911.
    View in: PubMed
    Score: 0,160
  29. Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
    View in: PubMed
    Score: 0,159
  30. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia. J Intern Med. 2019 06; 285(6):635-652.
    View in: PubMed
    Score: 0,146
  31. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Infect Dis (Lond). 2018 Jan; 50(1):13-20.
    View in: PubMed
    Score: 0,131
  32. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2016 12; 37(6):806-818.
    View in: PubMed
    Score: 0,126
  33. IgG subclasses in previously healthy adult patients with acute community-acquired pneumonia. S Afr Med J. 1996 May; 86(5 Suppl):600-2.
    View in: PubMed
    Score: 0,121
  34. Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit. Respir Med. 2015 Jun; 109(6):743-50.
    View in: PubMed
    Score: 0,112
  35. Lack of association of the caspase-12 long allele with community-acquired pneumonia in people of African descent. PLoS One. 2014; 9(2):e89194.
    View in: PubMed
    Score: 0,104
  36. HIV-associated bacterial pneumonia. Clin Chest Med. 2013 Jun; 34(2):205-16.
    View in: PubMed
    Score: 0,097
  37. Antibiotic resistance of pathogens causing community-acquired pneumonia. Semin Respir Crit Care Med. 2012 Jun; 33(3):232-43.
    View in: PubMed
    Score: 0,092
  38. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis. 2011 Apr; 15(4):542-6.
    View in: PubMed
    Score: 0,085
  39. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
    View in: PubMed
    Score: 0,079
  40. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis. 2010 Jan; 14(1):e22-7.
    View in: PubMed
    Score: 0,075
  41. Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect. 2007 Aug; 55(2):125-35.
    View in: PubMed
    Score: 0,065
  42. Prognostic scoring systems: which one is best? Curr Opin Infect Dis. 2007 Apr; 20(2):165-9.
    View in: PubMed
    Score: 0,064
  43. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. Clin Microbiol Infect. 2007 Feb; 13(2):162-171.
    View in: PubMed
    Score: 0,064
  44. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2006 Jul; 10(7):739-43.
    View in: PubMed
    Score: 0,061
  45. Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J. 2006 Jan; 27(1):9-11.
    View in: PubMed
    Score: 0,059
  46. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J. 2005 Apr; 25(4):688-92.
    View in: PubMed
    Score: 0,056
  47. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002; 8 Suppl 2:12-42.
    View in: PubMed
    Score: 0,045
  48. Prognostic factors in severe community-acquired pneumonia in patients without co-morbid illness. Respirology. 2001 Dec; 6(4):323-30.
    View in: PubMed
    Score: 0,044
  49. Pneumonia in the elderly. Clin Chest Med. 1999 Sep; 20(3):563-73.
    View in: PubMed
    Score: 0,038
  50. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia. Respir Med. 2018 07; 140:115-121.
    View in: PubMed
    Score: 0,035
  51. Severe community-acquired pneumonia. Curr Opin Pulm Med. 1997 Mar; 3(2):98-104.
    View in: PubMed
    Score: 0,032
  52. Community-acquired pneumonia in the ICU. Chest. 1995 Apr; 107(4):1182-3.
    View in: PubMed
    Score: 0,028
  53. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med. 1995 Mar; 89(3):187-92.
    View in: PubMed
    Score: 0,028
  54. A study of acute community-acquired pneumonia, including details of cardiac changes. Q J Med. 1993 Oct; 86(10):669-75.
    View in: PubMed
    Score: 0,025
  55. Factors associated with airway colonisation and invasion due to Klebsiella spp. S Afr Med J. 1993 Sep; 83(9):643-6.
    View in: PubMed
    Score: 0,025
  56. Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study. Eur J Clin Microbiol Infect Dis. 2012 Jan; 31(1):73-6.
    View in: PubMed
    Score: 0,021
  57. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011 Jan-Feb; 26(1):34-40.
    View in: PubMed
    Score: 0,021
  58. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis. 2005 Aug 15; 41(4):554-6.
    View in: PubMed
    Score: 0,014
  59. Appropriate use of the carbapenems. S Afr Med J. 2004 Oct; 94(10 Pt 2):857-61.
    View in: PubMed
    Score: 0,014
  60. Patterns of cytokine expression in community-acquired pneumonia. Chest. 1995 May; 107(5):1342-9.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.